FDA Inspection 1020609 — Shilpa Medicare Limited
The FDA completed an inspection of Shilpa Medicare Limited on Jul 28, 2017 in Jadcherla, Mahabubnagar District. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jul 28, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Jadcherla, Mahabubnagar District (India)